Immunological Data From Cancer Patients Treated With Ad5/3 E2F Δ24 GMCSF Suggests Utility for Tumor Immunotherapy
Oncotarget - United States
doi 10.18632/oncotarget.2901
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 13, 2015
Authors
Publisher
Impact Journals, LLC